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Abstract  
 
Objective 
To systematically review the research evidence on the effectiveness of homeopathy for 
the treatment of depression and depressive disorders 
 
Methods 
A comprehensive search of major biomedical databases including MEDLINE, EMBASE, 
ClNAHL, PsycINFO and the Cochrane Library was conducted. Specialist complementary 
and alternative medicine (CAM) databases including AMED, CISCOM and Hom-Inform 
were also searched. Additionally, efforts were made to identify unpublished and ongoing 
research using relevant sources and experts in the field. Relevant research was 
categorised by study type and appraised according to study design. Clinical commentaries 
were obtained for studies reporting clinical outcomes. 
 
Results 
Only two randomised controlled trials (RCTs) were identified.  One of these, a feasibility 
study, demonstrated problems with recruitment of patients in primary care. Several 
uncontrolled and observational studies have reported positive results including high 
levels of patient satisfaction but because of the lack of a control group, it is difficult to 
assess the extent to which any response is due to specific effects of homeopathy. Single 
case reports/studies were the most frequently encountered clinical study type.  We also 
found surveys, but no relevant qualitative research studies were located.  
 Adverse effects reported appear limited to ‘remedy reactions’ (‘aggravations’)  including 
temporary worsening of symptoms, symptom shifts and reappearance of old symptoms. 
These remedy reactions were generally transient but in one study, aggravation of 
symptoms caused withdrawal of the treatment in one patient. 
 
Conclusions 
A comprehensive search for published and unpublished studies has demonstrated that the 
evidence for the effectiveness of homeopathy in depression is limited due to lack of 
clinical trials of high quality. Further research is required, and should include well-
designed controlled studies with sufficient numbers of participants.  Qualitative studies 
aimed at overcoming recruitment and other problems should precede further RCTs. 
Methodological options include the incorporation of preference arms or uncontrolled 
observational studies. The highly individualised nature of much homeopathic treatment 
and the specificity of response may require innovative methods of analysis of  individual 
treatment response.   
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Comment [P1]:  
Introduction  
Mental health problems such as anxiety, depression and insomnia are among the most 
common reasons for individuals to seek treatment with complementary therapies in the 
US.1   This survey revealed that prevalence of the use of complementary and alternative 
medicine for the United States in 1997 was 42 per cent with chronic conditions, including 
depression and anxiety, comprising the conditions for which therapies were most 
frequently sought: 40.9% of adults with depression and 42.7% of adults with anxiety had 
used complementary therapies in the previous year.1 
 
Several surveys have focussed on the use of complementary and alternative medicine by 
patients with psychiatric disorders.  Davidson and colleagues conducted a study to 
determine the frequency of psychiatric disorders in patients receiving complementary 
medical care in the UK and the USA.2   Psychiatric disorders were relatively frequent 
among these patients. 74% of the British patients and 60.6% of the American patients had 
a lifetime psychiatric diagnosis. Major depression (52% of UK patients and 33.3% of 
USA patients) and any anxiety disorders were the commonest lifetime diagnoses.  46% of 
the UK patients and 30.3% of the USA patients had a current psychiatric diagnosis. Six 
per cent of the total currently suffered from a major depression and 25.3% of the total 
met the criteria for at least one anxiety disorder. A high rate of use of complementary 
therapies in adults who met criteria for common psychiatric disorders was also reported 
by Unutzer and colleagues.3 Respondents who met the criteria for major depression and 
panic disorder were particularly likely to report use.  Finally, a recent, large, prospective 
study of 3981 patients consulting classical homeopaths in Germany demonstrated a 
similar situation with depression among the 10 most frequent diagnoses encountered.4 
 
Depression  
Depression refers to a wide range of mental health problems characterised by the absence 
of a positive affect, low mood and a range of associated emotional, cognitive, physical 
and behavioural symptoms. Behavioural and physical symptoms typically include 
tearfulness, irritability, social withdrawal, reduced sleep, exacerbation of pre-existing 
pain and pain secondary to increased muscle tension and other causes, poor appetite,  lack 
of libido, fatigue and diminished activity, although agitation is also common and marked 
anxiety frequent. Along with a loss of interest and enjoyment in everyday life, feelings of 
guilt, worthlessness and deserved punishment are common, as are lowered self-esteem, 
loss of confidence, feelings of helplessness, suicidal ideation and attempts at self-harm or 
suicide. Cognitive changes include poor concentration and reduced attention, pessimistic 
and recurrently negative thoughts about oneself, one’s past and the future, mental slowing 
and rumination. 
 
Depression is the most common mental disorder in community settings, and is a major 
cause of disability across the world. In 1990, it was the fourth commonest cause of loss of 
disability adjusted life years in the world, and by 2020, it is projected to become the 
second commonest cause.5 The estimated point prevalence for major depression among 
16 to 65 year olds in the UK is 21/1000.  If the broader category of  "mixed depression 
and anxiety" is included, this rises to 98/1000.  Apart from the subjective suffering 
experienced by people who are depressed, the impact on social and occupational 
functioning, physical health and mortality is substantial. The impact on physical health 
sets depression alongside all the major chronic and disabling physical illnesses such as 
diabetes, arthritis and hypertension.6 
 
A range of therapeutic approaches are available, the most widely used, in developed 
countries, is antidepressant drugs.7  However these are associated with a number of 
problems including poor compliance and toxicity in overdose (particularly with the older 
tricyclic drugs) while the more modern selective serotonin uptake reinhibitor (SSRI) 
drugs are associated with increased incidence of self harm in young people and of suicide 
8,9
. Patients may turn to complementary therapies due to side effects of medication, time 
and effort associated with non-pharmacological therapies, lack of response or simply 
preference for the complementary approach. 
 
Homeopathy  
Homeopathy is among the most popular of CAM therapies and is widely used in western 
European countries including France, Germany, the Netherlands and the UK.  It is also 
popular elsewhere in the world, notably the Indian subcontinent and Latin America and 
there has been rapid recent growth of usage in the USA1.  Its perceived safety is an 
important factor motivating patients to use homeopathy.10 The extensive use of 
homeopathy, together with interest in homeopathy as a treatment for depression 11,12,13  
suggested that a review of the evidence for effectiveness in this condition would be 
valuable. 
Aim and objectives 
The aim of this study was to evaluate the evidence from a range of sources on the 
effectiveness (and safety and patient satisfaction) of homoeopathy for the treatment of 
depression. 
 
Methods 
 
Summary of search strategy 
A comprehensive search for clinical research was carried out. Systematic searches were 
conducted on a range of databases, citations were sought from relevant reviews and 
several websites were also included in the search, including those of MIND and the 
Mental Health Foundation.  
 
Databases searched 
General: 
ClNAHL, Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane 
Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, 
EMBASE, MEDLINE (and PubMed), PsycINFO, TRIP (Turning Research Into Practice) 
database 
 
Specialist CAM and condition based: 
AMED, CISCOM, Cochrane Complementary Medicine Field Registry, Hom-Inform, 
Cochrane Depression, Anxiety and Neurosis (CCDAN) Review Group trial register. 
 Search terms 
The basic search terms for homeopathy included: 
Exp homeopathy or Exp homeopathic drugs or Homoeop* or Homeop* 
 
Terms for depression included: 
Exp depression or Exp depressive disorder(s) or Exp dysthymia or Exp dysthymic 
disorder(s) or Depress* or Dysthym* or Mood or Affective disorder(s) 
 
Search strategies were adapted for each of the databases searched and the CCDAN 
register and Hom-Inform databases were searched by the information specialists 
responsible for these databases. Efforts were made to identify unpublished and ongoing 
research using relevant databases such as the National Research Register (UK) and 
Clinicaltrials.gov (US) together with experts in the field. Searches of databases (general 
and specialist) were initially conducted from inception up to October 2003 and then 
repeated in February 2004 and searches for unpublished studies carried out in May 2004.  
 
Filtering 
Relevant research was categorised by study type according to a flow-chart system 
developed for this project. The basic categories used are shown in Table 1. Animal 
research and basic lab-based research were not included in the categorisation process. 
 
Selection criteria 
 
Types of study  
• Initially only controlled studies were selected (randomised and non-randomised). 
As very few were located, other studies such as uncontrolled and observational 
studies were also included. Attempts were also made to locate relevant qualitative 
studies. 
 
• No language restrictions were imposed at the search and filtering stage and 
translations were obtained for any potentially relevant studies in languages other 
than English. 
 
Types of participants 
• Participants with a primary diagnosis of depression or a depressive disorder and 
those with depression as part of/a result of a physical illness 
 
Interventions 
• All forms of homeopathy including individualised and complex.  (Homeopathic 
complexes are fixed combinations of several homeopathic medicine) 
 
Outcome measures 
• Depression rating scales and patient focused measures such as satisfaction where 
relevant. 
Data collection and analysis 
 
Data was extracted systematically using a specially designed data extraction form. Data 
extracted included details of selection criteria and procedure, the participants, the 
intervention and any comparison or control intervention, aspects of the methodology and 
outcome measures and results.  Clinical trials were appraised using a standardised 
appraisal framework specifically developed for this project and based on criteria 
recommended in the Centre for Reviews and Dissemination Report Number 4 (2nd 
Edition), Undertaking Systematic Reviews of Research on Effectiveness.14 
 
Evaluation criteria included method of randomisation, allocation concealment and level 
of blinding (if relevant), method of dealing with missing values, loss to follow-
up/withdrawals, measures of compliance and outcomes measures reported. The full 
criteria are shown in the tables of studies. 
 
Data extraction and appraisal were conducted independently by two researchers (KP, 
GK) for each study and any disagreements or discrepancies were resolved by discussion. 
Where consensus could not be obtained, a third reviewer (JR) was available for 
consultation.  
 
Clinical commentaries 
Clinicians with training and experience in psychiatry and homeopathy and clinical 
research in these area (HR, PF) commented on studies focusing on clinical relevance and 
practical issues. Commentary frameworks were specifically developed for this project, 
these incorporate a number of closed and open questions with space for further 
comments. Summaries of these commentaries are provided in the tables of studies. 
 
Main results 
Types of study and numbers identified (Figure 1) 
 
Systematic reviews: 
• No systematic reviews specifically on the topic of homeopathy for depression 
were identified. One systematic review 15 included an RCT of patients with mixed 
anxiety and depression 16 (included under Controlled clinical trials)  
 
Controlled clinical trials: 
Depression as primary diagnosis 
• 2 RCTs 16,17  were identified 
 
Depression as secondary diagnosis/part of physical illness 
• 1 RCT (depression associated with chronic fatigue syndrome) 18,19  was located 
 
Other studies located: 
• 4 UCT/case series 20,21,22,23,24  
• 1 observational survey-based study 25 
• 1 multivariate analysis 26  
• Over 50 single case reports/studies 
• A number of surveys and patient outcome studies  
No relevant qualitative research studies were located 
 
Language of studies located 
Only one study in a language other than English was located 16.  A translation was 
obtained. 
 
The Evidence 
Based on conventional measures of quality and accepted study types, i.e. adequately 
randomised and controlled studies of sufficient power, no relevant studies were located. 
Those that were located were of low methodological quality, had insufficient numbers of 
participants or were uncontrolled. However, all located studies are presented in the tables 
together with comments on their methodology and clinical relevance in an attempt to 
highlight the issues to be addressed in future research in this area.  
 
Summary of each study 
Only one published randomised controlled trial examining the use of homeopathy for 
depression was located. This trial 16 , conducted in France, has been described previously 
as an ‘open randomised study’ 27 comparing homeopathic treatment with diazepam in 
patients with mixed anxiety and depressive states. Positive results for an homeopathic 
complex, a standardised proprietary formula, were reported.  In the criteria-based 
systematic review of Kleijnen and colleagues15 the trial scored only 45 out of 100 for 
methodological rigour, the cut off point for better studies was ≥55. The use of an 
anxiolytic drug as a control appears inappropriate in a trial in patients with depression 
and further appraisal of the study revealed a lack of information on many of the measures 
of trial quality; the method of randomisation, whether assessors were blinded, compliance 
and co-interventions. There were also problems in the diagnostic classification and 
inappropriate outcome measures were used. In subsequent meta-analyses and reviews, no 
further controlled trials specific to homeopathy and depression are cited. 28,29,30,31,32  
Studies conducted by the Homoeopathic Medicine Research Group, as a report to the 
European Commission, also failed to uncover any new controlled trials. 33,34 
 
A randomised controlled trial of homeopathy for depression in primary care was, 
however, conducted in 1999 at an East London group practice in collaboration with the 
Royal London Homeopathic hospital.17  The aim of this pilot study was to assess the 
feasibility of a general practice based trial comparing the effectiveness of individualised 
homeopathic treatment against fluoxetine (Prozac) and placebo. The methodology 
described is rigorous; randomised, double blind and double dummy. However, 
difficulties with recruitment resulted in only 11 participants being recruited to the study, 
4 in the treatment group with only 5 patients completing the study (personal 
communication). 
 
Davidson and colleagues reported homeopathic treatment of 12 patients with a range of 
diagnoses related to depression and anxiety disorders. 21 Full psychiatric diagnostic 
assessment together with a comprehensive homeopathic interview took place followed by 
individualised prescribing of the homeopathic treatment. 7 (58%) of patients were 
reported to have responded to homeopathic treatment, on the basis of the Clinical Global 
Improvement (CGI) scale, including 2 of the 3 patients with major depression. Type and 
potency of the remedies, duration of treatment and co-interventions varied between 
patients, as did the initial diagnoses leading to difficulties in interpreting the results. 
However, this study was considered relevant to practice and valuable as a preliminary 
report by a clinical commentator involved in the current review. 
 
There are several studies of the effects of homeopathy on mood or depression scores 
(among other outcomes), in patients with conditions such as cancer and chronic fatigue 
syndrome.  
 
A 1 year randomised controlled trial of the treatment of 64 patients with post viral fatigue 
syndrome or ME (myalgic encephalomyelitis), included self-assessed mood disturbance 
as an outcome measure and found greater improvement in the syndrome overall with 
patients treated with individualised homeopathy compared with those in the placebo 
group. 18,19 However, no other measures of mood or depression were taken and the 
significance of these results for patients with other conditions is unclear. For this reason, 
further details of this study are not included in the table of studies. 
 
The studies in cancer patients are all uncontrolled and involve the use of homeopathy to 
treat a range of problems.  Depression was only one of the problems reported and 
measured. These studies provide only relatively weak evidence of effectiveness, as lack 
of a control group and reporting of a range of outcomes leads to difficulties in 
interpretation of the results, particularly when assessing the extent to which any response 
is due to treatment with homeopathy. However, the findings are relevant to practice and 
therefore will be described here. 
 
Clover and colleagues reported a series of 50 cancer patients in whom response to 
homeopathy treatment had been assessed using the Hospital Anxiety and Depression 
Scale (HADS) and Rotterdam Symptom Checklist. 20 Improvements were seen on the 
psychological distress subscale of the latter when comparing scores on initial and later 
(3rd and 4th) visits and the percentage with normal HADS anxiety scores increased from 
48% to 75% over this period However, the lack a control group, variable co-interventions 
and loss to follow-up of 58% lead to difficulties in interpretation of these findings. 
 
More recently, in a well-designed uncontrolled clinical trial of the use of individualised 
homeopathy for symptom relief in 100 cancer patients, 52% of patients were found to 
have some improvement in depression scores at the end of the study period. 23  Up to 3 
symptoms perceived by the patient as problematic were rated on a self-rating scale. Mood 
disturbance was assessed using the Hospital Anxiety and Depression Scale (HADS). At 
the beginning of the study, 37 patients were depressed with 20 having a diagnosis of 
depression (scores above 10) and 17 borderline depression (scores 8-10). There was a 
significant improvement in the mean depression score for the whole study group, 
comparing the baseline score with either the average over all visits or just the last visit 
(p<0.05). Overall, 52% of patients were found to have some improvement in depression 
scores at the end of the study period (4-6 consultations later), with a mean improvement 
of 1.4 (95% CI 0.1-2.6). Attrition rate was high; only 52% completed the study and 17 
patients suffered an aggravation of symptoms or return of old symptoms considered to be 
previously described remedy reactions. No adverse reactions resulted in withdrawal of 
treatment. Satisfaction with treatment was measured by self-completion questionnaire 
and was high amongst those who completed the study; 75% regarded homeopathic 
treatment as having been helpful or better. 
 
In a further uncontrolled clinical trial of individualised homeopathy for symptoms of 
oestrogen withdrawal in 45 breast cancer patients, a significant improvement in 
depression score was found among women with depression, but not of the group overall. 
24
  Twenty-six of the patients had also been included in the 2002 study. 23  89% of 
patients completed this study and again satisfaction with treatment was high; 67% 
regarded homeopathic treatment as having been helpful, very helpful or extremely helpful 
for their symptoms. 
 
An observational survey-based study of homeopathic treatment in 269 women with 
gynaecological disorders, 38% of whom were assessed as having mood disorders has 
been reported .25  However, no information is given on diagnosis, the information was 
extracted from standardised questionnaires completed by 31 gynaecologists and the 269 
questionnaires returned represented a response rate of only 28.5%. Response to treatment 
was based on physician and patient assessment rated on a 5-point scale and for 67% of 
women in the study (calculated on an intention-to-treat basis) a ‘very good’ or ‘good’ 
improvement in their mood disorder symptoms was recorded. 
 
Finally, outcome studies including those of Clover 35, Richardson 36  and van 
Wassenhoven and Ives 13  have reported positive results in patients with a range of 
conditions including depression.  
 
In summary, only two randomised controlled trials were identified.  One of these, a 
feasibility study, is published in this issue of Homeopathy.  It demonstrated problems 
with recruitment of patients in primary care. Several uncontrolled and observational 
studies have reported positive results including high levels of patient satisfaction.  
Because of the lack of a control group, it is not possible to assess the extent to which any 
response is due solely to the homeopathy.  The interventions also varied including 
various types of homeopathy: individualised prescribing, ‘limited list’ prescribing and 
standardised complexes, further complicating interpretation of the findings.  
 
Adverse effects reported in the studies located appear limited to ‘aggravations’ including 
temporary worsening of symptoms, appearance of new symptoms and reappearance of 
old symptoms. These reactions were generally transient but in one study, aggravation of 
symptoms caused withdrawal of the treatment in one patient. 
 
Conclusions 
A comprehensive search for published and unpublished studies has demonstrated that the 
evidence for the effectiveness of homeopathy in depression is limited due to a lack of 
clinical trials of high quality.  When attempted, RCTs of good design have encountered 
problems, particularly with recruitment.  Similar problems have been encountered in 
other RCTs in depression.  The adverse effects reported in the studies were congruent 
with literature on the safety of homeopathy suggesting that homeopathic medicines may 
provoke adverse effects but these are relatively rare, mild and transient, although there is 
probably under-reporting.37,38 A recent systematic review of the frequency of 
homeopathic aggravations in the placebo and verum groups of double-blind, randomised 
clinical trials did not identify clear evidence of the existence of homeopathic 
aggravations39  contrary to the findings of audits in practice 40. The situation with regard 
to safety can be summed up as follows: 
“Homeopathic medications in high dilutions prescribed by trained professionals 
are probably safe and unlikely to provoke severe adverse reactions. It is difficult 
to draw definite conclusions due to the low methodological quality of reports 
claiming possible adverse effects of homeopathic medicines” 37 
 
Implications for the future 
If shown to be effective, homeopathy might be a useful therapeutic option in depression; 
potential benefits over existing treatments include high patient acceptability, lack of 
adverse effects and safety in overdose.  However the evidence base is currently weak. 
The main problem in RCTs of homeopathy for depression has been recruitment.  In 
principle it is possible to overcome this problem by using a very large recruitment base.   
However, this would be inefficient and the low recruitment ratio such a design implies 
means that the recruited subjects would likely be atypical.      
Further research is required, and should include well-designed controlled studies with 
sufficient numbers of participants. However, before launching such studies, development 
of methodologies and strategies to overcome recruitment problems is necessary. Patient 
preference, and the attitudes of health professionals appear to be important constraints to 
recruitment.  Qualitative studies aimed at identifying and understanding patients’ and 
health professionals’ perceptions and attitudes should precede further RCTs. 
Methodological options include the incorporation of preference arms or uncontrolled 
observational studies although both are less rigorous than RCTs.41, when well-designed, 
such studies give results similar to those of randomised controlled studies.42 The highly 
individualised nature of much homeopathic treatment and the claimed specificity of 
response justifies innovative methods of analysis of  individual response to treatment.  
For instance in ‘participant-centred analysis’, subjects are declared benefited, non-
responder or harmed, on the basis of a predefined decision rule. Variables associated with 
these responses can then be analysed.43 
Finally, a substantial number of case studies were located.  These provide an indication of 
the range of remedies employed in patients whose symptoms include depression. 
However, conclusions about the effectiveness of homeopathic treatment cannot be drawn 
from these because of factors such as preferential reporting of successful or unusual 
cases, and regression to the mean.  Such reports however might provide useful qualitative 
data concerning homeopathic treatment strategies, but synthesis of information from 
individual case reports is complex and impeded by a lack of structure and absent 
information in many reports. Efforts to encourage the publishing of high-quality 
structured case reports 44 , or consecutive case series of may help to address these 
problems. Methods aimed at utilising or synthesising data held with individual case 
studies either as a potential form of evidence or at least, as an illustration of how 
homeopathy is used in individuals with depression, may prove a valuable and rewarding 
approach in the future. 
 
Summary of studies  
See separate file 
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Figure 1 - Types of studies and numbers identified 
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 Table 1 – Categories of study types used 
 
RCT  randomised controlled trials 
CCT controlled clinical trials (without randomisation) 
UC studies uncontrolled studies including uncontrolled clinical trials and 
case series (further categorised according to the study 
population i.e. random sample, consecutive series or ‘best’ 
series) 
Case reports/studies reports of individual cases/patients 
Qualitative research study designs with a qualitative approach (including in-depth 
interviews and focus groups) 
Surveys large scale, primarily quantitative structured approaches 
Other research studies not falling into above categories  
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Summary of studies  
 
Depression as primary diagnosis 
 
Study Study 
design 
Sample Inclusion criteria CAM Rx Control Rx Outcome 
measure(s) 
Results Methodology 
comments 
Clinical 
comments 
Heulluy 
 
1985 
 
 
RCT  
(non-blinded)  
 
 
N= 60 
Tx= 30 
Ct= 30 
   
 
Setting and 
recruitment 
unknown 
 
‘Currently under 
consultation for 
depression, 
postmenopausal 
involution or 
thymo-effective 
dystonia’ 
 
 
 
 
Non – 
individualised 
L72 
(constituents 
not specified) 
(twenty drops 
4 times daily 
for 31 days) 
dose 
increased if 
required 
 
Diazepam 
(dose and 
frequency 
unknown) 
Ratio of pre 
and post 
scores for 
selected 
items on 
HAMD 
scale 
 
 
L72  as effective 
as diazepam on 
all measures 
(thymo-
effective, 
somatic and 
objective 
parameters) 
 
Negative 
outcomes: 
drowsiness (1 
case for L72, 2 
for diazepam) 
Unknown method of 
randomisation, 
concealment of 
allocation, whether 
blinded (not 
attempted?), loss to 
follow-up/withdrawals, 
co-interventions, 
compliance  
 
 
Intervention 
appropriate - 
Yes 
Control/placeb
o 
Appropriate - 
No/unclear 
Outcomes 
appropriate -  
No 
Diagnostic 
classification a 
problem 
 
Katz et al  
(unpublished) 
 
RCT pilot 
(triple arm 
parallel 
group)  
 
double-blind, 
double-
dummy 
 
 
 
N= 11  
Tx(H)= 4 
Ct(F)= 4 
Ct(Pl) = 3  
 
GP 
practice, 
East 
London. 
Recruited 
by GP 
homeopath 
 
 
Major depressive 
episodes of 
moderate severity, 
duration 4+ wks, 
HAMD score 17+.  
 
 
 
Limited list of 
30 remedies, 
trained 
homeopath 
using 
decision 
support 
software. 
Remedy 
unchanged, 
dilution and 
regime 
adjusted 
Duration: 12 
weeks 
Fluoxetine 
20mg daily 
increased to 
40mg after 4 
wks if no 
improvement 
in HAMD 
score and 
no adverse 
effects 
 
Placebo 
(matched 
tablets or 
capsules) 
Primary: 
HAMD, CGI 
Secondary: 
SF12, QoL 
quest., 
WSDS, 
Pittsburgh 
Sleep 
Quality 
Index 
quest. 
Treatment 
credibility 
Side Effects 
checklist 
Not reported 
due to low 
numbers 
Planned methodology 
rigorous except for 
compliance (self-
reported) and co-
interventions 
(unknown). However 
recruitment was 
problematic (11 
recruited) and loss to 
follow-up/withdrawals 
(6 completed)  
Not sent for 
clinical 
commentary 
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Study Study design Sample Inclusion 
criteria 
Homeopathy 
Rx 
Control Rx Outcome 
measure(s) 
Results Methodology 
comments 
Clinical 
comments 
Davidson et al 
 
1997 
UC study 
(best case 
series?)  
 
 
N= 12  
(3 with 
depression) 
  
US hospital or 
homeopathic 
hospital.  
Recruitment 
process 
unclear 
 
Social phobia, 
panic disorder, 
residual 
attention-deficit 
hyperactivity 
disorder, major 
depression, 
chronic fatigue 
syndrome 
 
 
Full 
psychiatric 
assessment 
and 
homeopathic 
interview 
then 
individualised 
prescribing 
Duration 
variable (7-
80 weeks) 
 
 
N/A CGI plus 
self-rated 
SCL-90 in 
the 
hospital, 
BSPS in 
the medical 
practice.  
 
Measures 
taken at 
variable 
intervals 
 
58% (7) 
recorded a 50% 
reduction on the 
CGI scale 
50% (6) 
recorded a 50% 
reduction on the 
SCL-90 or 
BSPS scale 
Response in2 
out of 3 patients 
with major 
depression  
Negative 
outcomes: none 
reported 
Not randomised, 
controlled or 
blinded. 
Compliance 
unknown 
Co-interventions – 
Drug and dose 
reported not 
frequency 
Intervention 
appropriate 
Yes 
Control/place
bo 
N/A 
Outcomes 
appropriate 
Yes 
 
Very 
relevant, 
excellent 
preliminary 
report 
 
Depression as secondary diagnosis  
 
Study Study 
design 
Sample Inclusion 
criteria 
Homeopathy 
Rx 
Control 
Rx 
Outcome 
measure(s) 
Results Methodology 
comments 
Clinical 
comments 
Clover et 
al  
 
1995 
UC study  
 
(consecutive 
case series)  
N= 50  
 
Referral to 
UK 
homeopathic 
hospital 
 
 
 
 
Cancer-
related 
symptoms 
(including 
mood 
disturbance) 
Individualised 
homeopathy 
None HADS 
Rotterdam 
Symptom 
Checklist 
(RSCL) 
 
Initial, 2nd, 3rd 
and 4th clinic 
attendances 
 
Improvements on 
the psychological 
distress subscale 
of RSCL 
comparing initial 
scores with 3rd 
and 4th visits (p< 
0.005 and <0.02).  
Improvement in 
HADS Anxiety 
Not randomised or 
blinded 
Loss to follow-
up/withdrawals: 58% 
(29) reasons 
documented (15 died, 
0 lost to follow-up) 
Co-interventions and 
other confounders: 29 
(58%) prescribed SC 
Intervention 
appropriate 
Yes 
Control/placebo 
N/A 
Outcomes 
appropriate 
Yes (for quality 
of life) 
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subscale initial vs 
3rd visits scores 
(p<0.01). (Initial 
visit 48% patient 
with normal 
HADS anxiety 
scores, 75% at 4th 
visit) 
or oral iscador, 
50% relaxation, 14% 
acupuncture, 34% 
CAM elsewhere 
Well-designed 
and pragmatic 
cohort study 
Thompson 
and Reilly 
 
2002 
UC study  
 
(consecutive 
case series) 
 
 
 
 
N= 100  
  
Referral to 
UK 
homeopathic 
hospital 
cancer clinic 
 
 
Cancer-
related 
symptoms 
(including 
mood 
disturbance) 
 
 
 
Sixty minute 
consultation 
and 
prescription 
of 
individualised 
remedy 
 
Duration – 
variable 
N/A Self-rating of 
symptoms on 
11 point scale 
HADS 
EORTCQLQ-30 
 
At initial 
consultation 
and 4-6 
consultations 
later 
Initially 59 with 
anxiety, 37 with 
depression. 
For patients with 
at least 2 follow-
ups mean anxiety 
scores improved 
by 1.6 (95%CI 
0.4-2.9), mean 
depression scores 
by 1.4 (0.1-2.6) 
Negative: 17 
patients with 
aggravation/return 
of old symptoms 
Not randomised or 
blinded 
Loss to follow-
up/withdrawals: 44% 
56 completed (26 
died, 18 defaulted) 
Co-interventions and 
other confounders: 
unknown 
Intervention 
appropriate 
Yes 
 
Control/placebo 
N/A 
 
Outcomes 
appropriate 
Yes 
 
Excellent case 
series/cohort 
study 
 
 
Thompson 
and Reilly 
 
2003 
UC study 
 
(consecutive 
case series)  
N= 45  
(26 from 
previous 
study) 
 
Outpatients 
at UK 
homeopathic 
hospital 
Breast cancer 
patients with 
symptoms of 
oestrogen 
withdrawal 
(including 
mood 
disturbance) 
 
60 minute 
consultation 
and Rx of 
individualised 
remedies (25 
of variable 
potency, 30% 
as LM, for up 
to 3 
symptoms). 
Pulsatilla, 
N/A Score of an 
effect on daily 
living of 3 
symptoms 
(unvalidated) 
Scales were 
used at every 
consultation 
Symptom 
scores 
HADS 
Significant 
improvement in all 
3 main symptoms 
 
Mean anxiety 
scores improved 
by 2.1 (0.7-3.4) 
 
Mean depression 
scores improved 
by 1 (-0.1-2.1) not 
Not randomised or 
blinded 
Loss to follow-
up/withdrawals: 11% 
40 completed (1 died, 
4 defaulted) 
Co-interventions and 
other confounders: 
conventional cancer 
treatment, (55% 
tamoxifen, 48% 
Intervention 
appropriate: 
Yes 
 
Control/placebo  
N/A 
 
Outcomes 
appropriate: 
Yes 
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Sepia and 
Sulphur each 
given on 
more than 3 
occasions as 
first Rx. 
 
Duration –
variable 
 
EORTCQLQ-30 
(at initial 
consultation 
and 3-5 
consultations 
later) 
 
 
significant 
p=0.067 
Negative : 7 with 
new symptoms, 
10 with return of 
old symptoms. 1 
withdrew due to 
aggravation of 
symptoms 
adjuvant 
chemotherapy, 44% 
other medication 
including 
antidepressants) 
Good study 
design but see 
Thompson et al 
2002 
Zenner 
and 
Weisner 
 
1999 
UC study  
 
 
(prospective, 
multicentre 
outcome 
based) 
N= 269  
 
Patients 
seen by one 
of 31 
gynaecologi
sts, 
Germany 
Gynaecologic
al disorders 
(including 102 
with mood 
disorders) 
Proprietary 
homeopathic 
remedy – 
Mulimen*    
given as 
drops (in 
83% 
patients) or 
injection  
N/A Improvement in 
symptoms 
 
Patient and 
physician final 
evaluation on 5 
point scale 
 
Tolerance on 4 
point scale 
Very good/good 
for between 75-
80% cases for 
mood disorders 
(n=88) 
 
77% recorded 
good/very good 
improvement in 
symptoms 
 
 
Not randomised or 
controlled 
Loss to follow-
up/withdrawals:  
results for 221/269 
(82%) but response 
rate for questionnaire 
28.5% 
Co-interventions and 
other confounders:  
18% other 
medications, 2% 
other therapies 
Intervention 
appropriate: 
Yes 
 
Control/placebo 
N/A 
 
Outcomes 
appropriate: 
Unsure 
 
 
* constituents: Ambra grisca 4X, Calcium carbonicum Hahnemanni 8X,, Cimicifuga racemosa 4X, Gelsemium sempervirens 4X, Hypericum perforatum 3X, Kalium 
carbonicum 4X, Sepia officinalis 8X, Urtica urens 3X, Vitex agnus-castus 3X  
 
Abbreviations: RCT randomised controlled trial, CCT controlled clinical trial, UC uncontrolled, DARE Database of Reviews of Effects, H homeopathy, D diazepam, 
HAMD Hamilton Depression Scale, P placebo, F fluoxetine, CGI Clinical Global Impression, QoL quality of life, WSDS Work and Social Disability Scale, BSPS Brief 
Social Phobia Scale, SCL-90 outpatient psychiatric rating scale, HADS Hospital Anxiety and Depression Scale, RSCL Rotterdam Symptom Checklist, EORTCQLQ-
30 European Organisation for Research and Treatment in Cancer – Quality of Life Questionnaire – Core 30, 
 
Research on patient satisfaction and experience with the therapy 
• No qualitative studies were located  
• The following studies addressed patient satisfaction and/or used patient outcome measures 
Homeopathy in depression table of studies 
 
Study Study design Results 
Thompson 
2002 
Questionnaire (as 
part of study above) 
75% of patients regarded homeopathic treatment as having been helpful or very helpful for their symptoms 
Thompson 
2003 
Questionnaire 90% of patients rated their satisfaction as 7 or above on a 10 point scale (0=completely dissatisfied; 10=completely satisfied). 
67% of patients regarded the homeopathic approach as helpful, very helpful or extremely helpful for their symptoms. 21% 
valued talking about the problem above the remedy, 36% valued both equally, 43% valued the remedy above talking 
 
